Skip to content

Food and Drug Regulations

C.R.C., c. 870

In forceCurrent to September 30, 2026 HistoryMade under: Food and Drugs Act

Follow

Part C — Drugs › Division 8

New Drugs

Section C.08.002.02

 Despite sections C.08.002 and C.08.003, no manufacturer or importer shall sell a new drug for extraordinary use in respect of which a notice of compliance has been issued under section C.08.004.01 except to

  • (a) the Government of Canada or the government of a province for the use of a department or agency of that government, on receipt of a written order signed by the minister responsible for the department or by the person in charge of the agency, or by their duly authorized representative; or

  • (b) a municipal government, or an institution of such a government, on receipt of a written order signed by a senior official of the government or institution or by his or her duly authorized representative.

  • SOR/2011-88, s. 11
.

Version in force since March 25, 2011

Unofficial reproduction of the consolidated text published by the Department of Justice Canada, permitted by the Reproduction of Federal Law Order. Only the official text is authoritative.